Published: Fri, April 14, 2017
Economy | By Melissa Porter

Freeport-McMoRan Inc. (FCX), Pfizer Inc. (PFE)

Freeport-McMoRan Inc. (FCX), Pfizer Inc. (PFE)

The stock has an average rating of "Hold" and a consensus price target of $13.85. This rating was issued on 3/22/17.

Freeport-McMoRan Inc. closed its last trading session at $13.62 with the loss of -5.43%. Price targets reflect what the analyst believes a stock will be worth four quarters into the future. The stock was sold at an average price of $15.42, for a total value of $888,500.40. These analysts and investment firms use various valuation methods to decide a price target for a stock.

According to these analysts, the Low Revenue Estimate for Freeport-McMoRan 3.31 Billion and the High Revenue Estimate is 4.01 Billion. BMO Capital Markets restated a hold rating and issued a $15.00 price target on shares of Freeport-McMoRan in a research note on Thursday, December 29th.

ILLEGAL ACTIVITY WARNING: "Freeport-McMoRan Inc (FCX) Upgraded by Vetr "Strong-Buy" was posted by Markets Daily and is the property of of Markets Daily. Deutsche Bank Downgrades the stock to Sell on 2/21/17 by stationing a price target of $12.5. Finally, Johnson Investment Counsel Inc. boosted its position in shares of Freeport-McMoRan by 6.4% in the third quarter.

Several hedge funds and other institutional investors have recently bought and sold shares of FCX.

Comparatively, Freeport-McMoRan Inc. posted earnings of $0.26 per share in the same quarter previous year.

The stock volatility for week was 2.56% while for month was 3.36%.The stock, as of last close, traded 49.89% to its 52 week low and was changed -20.75% from its 52 week high. For the Current Quarter, 17 analysts are projecting the mean EPS to be $0.27/share. The analyst recommendations from a month ago are 3 Buy, 0 Overweight, 3 Sell, 16 Hold and 1 Underweight. The return on invested capital at -14.2%, which is good, compared to its peers. This scale runs from 1 to 5 where 1 represents Strong Buy and 5 represents Sell. Freeport-McMoRan's revenue for the quarter was up 24.5% compared to the same quarter previous year. On average, analysts predict that Freeport-McMoRan will post $1.05 earnings per share for the current year. (PFE) reported its EPS in the last quarter as $0.47/Share lagging the analyst estimate of $0.5/Share by the difference of $-0.03. Thus the company showed an Earnings Surprise of -26.5 Percent. The stock's market capitalization is $18.66 billion. The stock had a trading volume of 22,638,466 shares. It opened the session with a $2.63 price tag, later ranging from $2.3 to $2.64, the range at which the stock has traded at throughout the day.

Freeport-McMoRan Inc. (FCX)'s distance from 200 day simple moving average is 4.32 percent, its distance from 50 day simple moving average is -4.45 percent, while its distance from 20 day simple moving average is 3.88 percent.

According to Finviz reported data, The SMA20 of the stock is at 4.98 percent, SMA50 is -1.96 percent, while SMA200 is 6.08 percent.

Pfizer Inc. (PFE) is now trading with the volume of 10.94 Million. Freeport-McMoRan had a negative net margin of 28.09% and a positive return on equity of 3.52%.

While looking at the Stock's Performance, Freeport-McMoRan Inc. now shows a Weekly Performance of -4.17%, where Monthly Performance is 4.97%, Quarterly performance is -18.84%, 6 Months performance is 30.5% and yearly performance percentage is 19.04%.

"Depending what will happen in the coming months and years in terms of negotiations with the government, the extension beyond 2021, Rio will have to come to a conclusion whether we want to stay or not", Jacques said, adding discussions involving all parties would continue over the next six months.

Freeport-McMoRan Inc (FCX) is a mining company. The Stock opened today's session at $33.88 and now the price is hovering at $33.75 by showing decrease of -0.53 percent. FCX has P/E (Price to Earnings ttm) value of 0, Forward P/E of 9.42, P/C (Price to cash per share) of 4.45 and Price to Free Cash Flow (P/FCF) value of 17.4. Following the completion of the sale, the chief operating officer now directly owns 37,763 shares of the company's stock, valued at approximately $575,508.12.

Like this: